Company Profile

UPL LTD.

NSE : UPLBSE : 512070ISIN CODE : INE628A01036Industry : Pesticides & AgrochemicalsHouse : Rajju Shroff
BSE819.703.05 (+0.37 % )
PREV CLOSE (Rs.) 816.65
OPEN PRICE (Rs.) 817.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 819.70 (226 )
VOLUME 36354
TODAY'S LOW / HIGH (Rs.)806.60 823.05
52 WK LOW / HIGH (Rs.)537.9 824.6
NSE821.85 3.5 (+0.43 % )
PREV CLOSE(Rs.) 818.35
OPEN PRICE (Rs.) 819.25
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 1903214
TODAY'S LOW / HIGH(Rs.) 806.05 830.00
52 WK LOW / HIGH (Rs.)537.25 824.5

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 297.99
Dividend Yield(%) 0.98
TTM EPS (Rs.) 7.54
P/E Ratio 108.70
Book Value (Rs.) 158.20
Face Value (Rs.) 2
MCap (Rs. in Mn) 417406.32
Price/Earning (TTM) 38.40
Price/Sales (TTM) 4.95
Price/Book (MRQ) 5.18
PAT Margin (%) 7.43
ROCE (%) 8.04
Incorporation Year : 1985

Management Info :

R D Shroff - Chairman R D Shroff - Managing Director

Registered Office :

Address : 3 - 11 , G I D C,Vapi, ,
Valsad,
Gujarat-396195

Phone : 0260-2400717

Website : www.uplonline.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, Luxembourg, MCX
NEWS More
15Feb02-15-2019$UPL informs about disclosure UPL informs about disclosure

UPL has informed about the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shilpa Pradeep Sagar.

The above information is a part of company's filings submitted to BSE.


UPL has informed about the disclosure under Regulation 29(2) of..
01Feb02-01-2019$UPL reports 20% fall in Q3 consolidated net profit UPL reports 20% fall in Q3 c

UPL has reported results for third quarter ended December 31, 2018.

The company has reported a fall of 93.10% in its net profit at Rs 10.00 crore for the quarter under review as compared to Rs 145.00 crore for the same quarter in the previous year. However, total income of the company increased by 13.54% at Rs 2,231.00 crore for Q3FY19 as compared Rs 1,965.00 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a fall of 19.69% in its net profit at Rs 461.00 crore for the quarter under review as compared to Rs 574.00 crore for the same quarter in the previous year. However, total income of the company increased by 14.95% at Rs 4,958.00 crore for Q3FY19 as compared Rs 4,313.00 crore for the corresponding quarter previous year.

UPL has reported results for third quarter ended December 31, 2..
31Jan01-31-2019$ Loss of Share Certificate / Issue of Duplicate Share Certificate Loss of Share Certificate /
UPL Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate.
UPL Ltd has informed BSE regarding Loss of Share Certificate /..
24Jan01-24-2019$ Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Disclosure Under Regulation
We would like to inform you that UPL Ltd had made an announcement to the stock exchange on 20 July 2018 for acquisition ('Transaction') of 100% shares of Arysta LifeScience Inc. and its subsidiaries from Platform Speciality Products Corporation, an entity listed in the United States of America. The acquisition was subject to various regulatory approvals. The parties have now obtained all regulatory approvals necessary to complete the Transaction. The Transaction is expected to close on 31 January 2019. May we request you to take the same on your record and inform all your constituents accordingly.
We would like to inform you that UPL Ltd had made an announceme..
21Jan01-21-2019$ Board Meeting Intimation for INTIMATION OF BOARD MEETING Board Meeting Intimation fo
UPL Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2019 ,inter alia, to consider and approve We wish to inform you, pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 that a Meeting of the Board of Directors of the Company is scheduled to be held on Thursday, the 31st January, 2019 to, inter-alia, consider and take on record the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 31st December, 2018. In view of the above and in pursuance of the Company's ''Code of Conduct for Prevention of Insider Trading' framed under SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in shares of the Company will remain closed from 21st January, 2019 and will end on 2nd February, 2019 for Insiders covered therein. Thanking you, Yours faithfully, for UPL Limited M. B. Trivedi Company Secretary and Compliance Officer (ICSI Membership No. ACS-4250)
UPL Limitedhas informed BSE that the meeting of the Board of Di..
Financials More
Rs. in Millions
QTR Dec 18 ANNUAL 18
Net Profit1005480
Gross Profit 130 5760
Operating Profit 195014150
Net Sales 2216073740
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Bayer CropScience (BSE)
 4399.00 (2.75%)
M.Cap ( in Cr)
14578.04
Bhagiradha Chem (BSE)
 400.00 (1.52%)
M.Cap ( in Cr)
332.39
Kilpest India (BSE)
 71.35 (7.94%)
M.Cap ( in Cr)
45.66
PI Industries (BSE)
 895.00 (0.29%)
M.Cap ( in Cr)
12196.39
Ocean Agro (India) (BSE)
 18.05 (4.94%)
M.Cap ( in Cr)
11.50
Shareholding Pattern More
MUTUAL FUNDS/UTI 8.93 %
PROMOTERS 27.92 %
NON-INSTITUTION 11.97 %
FI/BANKS/INSURANCE 0.6 %
GOVERNMENT 0.35 %
FII 0 %
F & O Quotes

Open A

New Account

Name
Email
Mobile Number
City
Select Products You Are Interested